Cargando…
Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma
mTOR activation has been observed in rhabdomyosarcoma (RMS); however, mTOR complex (mTORC) 1 inhibition has had limited success thus far. mTOR activation alters the metabolic pathways, which is linked to survival and metastasis. These pathways have not been thoroughly analyzed in RMSs. We performed...
Autores principales: | Felkai, Luca, Krencz, Ildikó, Kiss, Dorottya Judit, Nagy, Noémi, Petővári, Gábor, Dankó, Titanilla, Micsík, Tamás, Khoor, András, Tornóczky, Tamás, Sápi, Zoltán, Sebestyén, Anna, Csóka, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409076/ https://www.ncbi.nlm.nih.gov/pubmed/32709151 http://dx.doi.org/10.3390/cancers12071947 |
Ejemplares similares
-
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations
por: Krencz, Ildiko, et al.
Publicado: (2021) -
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
por: Sebestyén, Anna, et al.
Publicado: (2022) -
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022) -
In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
por: Mohás, Anna, et al.
Publicado: (2022) -
3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures
por: Sztankovics, Dániel, et al.
Publicado: (2023)